DRTECH Corporation - Asset Resilience Ratio
DRTECH Corporation (214680) has an Asset Resilience Ratio of 4.69% as of September 2025. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing.
Liquid Assets
Total Assets
Resilience Assessment
Asset Resilience Ratio Trend (2016–2024)
This chart shows how DRTECH Corporation's Asset Resilience Ratio has changed over time. Check DRTECH Corporation (214680) strategic asset index to assess the company's strategic physical and investment asset allocation.
Liquid Assets Composition Over Time
This chart breaks down DRTECH Corporation's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For market capitalisation and broader financial context, see DRTECH Corporation (214680) total market value.
Current Liquid Assets Breakdown
| Component | Amount | % of Total Assets |
|---|---|---|
| Cash & Equivalents | ₩0.00 | 0% |
| Short-term Investments | ₩9.78 Billion | 4.69% |
| Total Liquid Assets | ₩9.78 Billion | 4.69% |
Asset Resilience Insights
- Limited Liquidity: DRTECH Corporation maintains only 4.69% of assets in liquid form.
- This low level may indicate efficient asset utilization but could pose risks during economic downturns.
- The company has significant short-term investments, indicating active treasury management.
DRTECH Corporation Industry Peers by Asset Resilience Ratio
Compare DRTECH Corporation's asset resilience ratio with other companies in the same industry.
| Company | Industry | Asset Resilience Ratio |
|---|---|---|
|
Bio-Rad Laboratories Inc
NYSE:BIO |
Medical Devices | 10.80% |
|
Double Medical Technology Inc
SHE:002901 |
Medical Devices | 12.59% |
|
Tellgen Corp
SHE:300642 |
Medical Devices | 9.96% |
|
Affluent Medical SAS
PA:AFME |
Medical Devices | 0.03% |
|
Cochlear Ltd
AU:COH |
Medical Devices | 9.76% |
|
Anteris Technologies Global Corp
AU:AVR |
Medical Devices | 33.27% |
|
Imricor Medical Systems Inc
AU:IMR |
Medical Devices | 46.50% |
|
Polynovo Ltd
AU:PNV |
Medical Devices | 0.04% |
Annual Asset Resilience Ratio for DRTECH Corporation (2016–2024)
The table below shows the annual Asset Resilience Ratio data for DRTECH Corporation.
| Year | Asset Resilience Ratio (%) | Liquid Assets | Total Assets | Change |
|---|---|---|---|---|
| 2024-12-31 | 12.69% | ₩22.75 Billion ≈ $15.42 Million |
₩179.35 Billion ≈ $121.54 Million |
-2.18pp |
| 2023-12-31 | 14.87% | ₩24.39 Billion ≈ $16.53 Million |
₩164.02 Billion ≈ $111.15 Million |
-4.93pp |
| 2022-12-31 | 19.80% | ₩23.91 Billion ≈ $16.20 Million |
₩120.78 Billion ≈ $81.85 Million |
+2.29pp |
| 2021-12-31 | 17.51% | ₩16.44 Billion ≈ $11.14 Million |
₩93.90 Billion ≈ $63.63 Million |
-8.39pp |
| 2020-12-31 | 25.90% | ₩23.78 Billion ≈ $16.12 Million |
₩91.81 Billion ≈ $62.22 Million |
+5.58pp |
| 2019-12-31 | 20.33% | ₩14.42 Billion ≈ $9.78 Million |
₩70.96 Billion ≈ $48.09 Million |
+14.77pp |
| 2018-12-31 | 5.55% | ₩2.77 Billion ≈ $1.87 Million |
₩49.80 Billion ≈ $33.75 Million |
+0.14pp |
| 2017-12-31 | 5.41% | ₩2.35 Billion ≈ $1.60 Million |
₩43.51 Billion ≈ $29.49 Million |
+0.70pp |
| 2016-12-31 | 4.72% | ₩1.77 Billion ≈ $1.20 Million |
₩37.62 Billion ≈ $25.49 Million |
-- |
About DRTECH Corporation
DRTECH Corporation develops and sells flat-panel X-ray detectors for digital radiography in South Korea and internationally. Its products include detectors for general radiography, mammography, dynamic, dental, veterinary, and industrial applications; imaging solutions, including specialized UI software, dual energy x-ray imaging, AI imaging processing, advanced image reconstruction technology, a… Read more